Abstract
The affective disorders are mania and depression. Depression, more than mania, has been subject to a variety of systems of subclassification (Schatzberg, 1976). Since both mania and depression tend notoriously to recur, it is often possible in a given patient to base diagnosis on life history (Mazure and Gershon, 1979). Thus, one may speak of a depressed patient as showing either the bipolar or the unipolar form of the disorder; respectively, the patient has or has not suffered a previous manic attack. “Mania” almost always implies bipolar affective disorder, for mania without diagnosable episodes of depression, i.e., unipolar mania, is rare. This simple classification, now generally accepted, corresponds reasonably well to an assortment of biological findings (Goodwin and Potter, 1976) and treatment responses (Schildkraut et al., 1976). Whenever possible, we shall use it in the discussion that follows.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Altschule, M.D., Siegal, E.P., and Hennemann, D.H. Carbohydrate metabolism in brain disease: VI I. The effect of glutathione on carbohydrate intermediary metabolism in schizophrenic and manic-depressive psychoses. AMA Arch. Int. Med. 99, 22–27 (1957).
Arana G., Boyd, A.E., Reichlin, S., and Lipsitt, D. Prolactin levels in depression. Psychosom. Med. 39, 193–197 (1977).
Benkert, O. Studies on pituitary hormones and releasing hormones in depression and sexual impotence, in Hormones. Homeostasis and the Brain. Progress in Brain Research 42, W.H. Gispen, Tj. B. van Wimersma Greidanus, B. Bohus, and D. deWied, eds. Elsevier, Amsterdam (1975), pp. 25–36.
Benkert, O., Gordon, A., and Martschke, D. The comparison of thyrotropin releasing hormone, luteinising hormone-releasing hormone and placebo in depressive patients using a double-blind cross-over technique. Psychopharmacologia (Berl.) 40, 191–198 (1974).
Berthold, A.A. Transplantation der hoden. Arch. Anat. Physiol. Wiss. Med. 16, 42 (1849).
Betts, T.A., Smith, J., Pidd, S., Mackintosh, J., Harvey, P., and Funicane, J. The effects of thyrotropin-releasing hormone on measures of mood in normal women. Brit. J. Clin. Pharmacal. 3, 469–473 (1976).
Blume, A.J., Sharr, J., Finberg, J.P.M., and Spector, S.S. Binding of the endogenous nonpeptide morphine-like compound to opiate receptors. Proc. Natl. Acad. Sci. USA 74(11), 4931 (1977).
Boler, J., Enzmann, F., Folkers, K., Bowers, C.Y., and Schally, A.V. The identity of chemical and hormonal properties of the thyrotropin releasing hormone and pyroglutamyl-histidylproline-amide. Biochem. Biophys. Res. Commun. 37, 705 (1969).
Bowers, c.y., Friesen, N.G., Hwang, P., Guyda, H.Y., and Folkers, K. Prolactin and thyrotropin release in man by synthetic pyroglutamyl-histidyl-prolinamide. Biochem. Biophys. Res. Commun. 45, 1033–1041 (1971).
Brownstein, M.J., Palkovits, M., Saavedra, J.M., and Kizer, J. Distribution of hypothalamic hormones and neurotransmitters within the diencephalon, in Frontiers in Neuroendocrinology. L. Martini, and W.F. Ganong, eds. Raven Press, New York (1976), pp. 1–23.
Burgus, R., Dunn, T.F., Desiderio, D., and Guillemin, R. Structure moleculaire de facteur hypothalamique hypophysiotrope TRH d’origine ovine: Mise en evidence par spectrometrie de masse de la sequence PCA-His-Pro-NH2. C.R. Acad. Sci. (Paris), 269, 1870–1873 (1969).
Carroll, B.J. and Mendels, J. Neuroendocrine regulation in affective disorders, in Hormones. Behavior and Psychopathology. E.J. Sacher, ed. Raven Press, New York, (1976), pp. 41–68.
Chazot, G., Chalumeau, A., Aimard, G., Mornes, R., Garde, A., Schott, B., and Girard P.F. Thyrotropin releasing hormone and depressive states: from agroagonines to TRH. Lyon Medical 231, 831–836 (1974).
Coppen, A., Montgomery, S., Peet, M., and Bailey, J. Thyrotropin-releasing hormone in the treatment of depression. Lancet ii, 433–434 (1974).
Coppen, A., Prange, A.J., Jr., Whybrow, P.c., and Noguera, R. Abnormalities of indoleamines in affective disorders. Arch. Gen. Psychiat. 26, 474–478 (1972).
Costa, E., and Trabucchi, M. The Endorphins. Raven Press, New York (1978).
Cowie, D., Parsons, J.P., and Raphael, T. Insulin and mental depression. Arch. Neur. Psych. 12, 522 (1924).
Daughaday, W.H. The adenohypophysis, in Textbook of Endocrinology. R.H. Williams, ed. W. B. Saunders Co., Philadelphia (1974).
Davis, K.L., Berger, P.A., Hollister, L.E., and Defraites, E. Physostigmine in mania. Arch. Gen. Psychiat. 35, 119–122 (1978).
Davis, G.c., Bunney, W.E., Jr., Defraites, E.G., Kleinman, J.E., van Kammen, D.P., and Wyatt, R.J. Intravenous naloxone administration in schizophrenia and effective illness. Science 197, 74–77 (1977).
DeWied, D. The role of the posterior pituitary and its peptides on the maintenance of conditioned avoidance behavior, in Hormones and Brain Function. K. Lissak, ed. Plenum Press, New York (1973).
DeWied, D., and Gispen, W.H. Behavioral effects of peptides, in Peptides in Neurobiology. H. Gainer, ed. Plenum Press, New York (1977).
DeWied, D., Bohus, B., Urban, I., van Wimersma Greidnus, Tj.B., and Gispen, W.H. Pituitary peptides and memory, in Peptides: Chemistry Structure and Biology. R. Walter and J. Meienhofer, eds. Ann Arbor Publishers, Ann Arbor, Michigan (1975).
Dimitrikoudi, M., Hanson-Norty, E., and Jenner, F.A. T.R.H. in psychoses. Lancet i, 456 (1974).
Ehrensing, R.H., and Kastin, A.J. MSH release-inhibiting hormone as an antidepressant. Arch. Gen. Psychiat. 30, 63–65 (1974).
Ehrensing, R.H. and Kastin, A.J. Dose-related biphasic effect of prolyl-leucyl-glycinamide (MIF-I) in depression. Am. J. Psychiat. 135, 562–566 (1978).
Ehrensing, R.H., Kastin, A.J., Schalch, D.S., Friesen, H.G., Vargas, J.R., and Schally, A.V. Affective state and thyrotropin and prolactin responses after repeated injections of thyrotropin-releasing hormone in depressed patients. Am. J. Psychiat. 131(6), 714–718 (1974).
Endroczi, E. Pavlovian conditioning and adaptive hormones, in Hormones and Behavior. S. Levine, ed. Academic Press, New York (1972), pp. 173–208.
Ettigi, P.G., and Brown, G. TSH and LH responses in subtypes of depression. Annual Meeting. American Psychosomatic Society, Washington, D.C., (March 1978).
Forizs, L., Vitols, E., and Vitols, M. Combined pitressin and electric shock in schizophrenia. Dis. Nerv. Syst. 15, 176–179 (1954).
Furlong, F.W., Brown, G.M, and Beeching, M.R. Thyrotropin-releasing hormone: Differential antidepressant and endocrinological effects. Am. J. Psychiat. 133, 1187–1190 (1976).
Goetsch, E. Newer methods in the diagnosis of thyroid disorders: Pathological and clinical. N. Y. State J. Med. 18, 259–267 (1918).
Gold, P.W., Goodwin, F.K., and Reus, V.I. Vasopressin in affective illness. Lancet i, 1233–1236 (1978).
Gold, P.W., Goodwin, F.K., Wehr, T., and Rebar, R. Pituitary thyrotropin response to thyrotropin-releasing hormone in affective illness: Relationship to spinal fluid amine metabolites. Am. J. Psychiat. 134(9), 1028–1031 (1977).
Goldstein, A. Opioid peptides in pituitary and brain. Science 193, 1081–1086 (1976).
Goodwin, F.K., and Potter, W.Z. The biology of affective illness: Amine neurotransmitters and drug response, in Depression, Biology, Psychodynamics and Treatment. J.O. Cole, A. F. Schatzberg, and S.H. Frazier, eds. Plenum Press, New York (1976).
Gregoire, F., Brauman, H., de Buck, R., and Corvilain, J. Hormone release in depressed patients before and after recovery. Psychoneuroendocrinology 2, 303–312 (1977).
Gruen, P.H., Sachar, E.J., Altman, N., and Sassin, J. Growth hormone responses to hypoglycemia in postmenopausal depressed women. Arch. Gen. Psychiat. 32, 31–33 (1975).
Guillemin, R. Peptides in the brain: The new endocrinology of the neuron. Science 202, 390–402 (1978).
Hamilton, M. A rating scale for depression. J. Neurol. Neurogsurg. Psychiat. 23, 56–62 (1960).
Heninger, G.R., Mueller, P.S., and Davis, L.S. Responsivness of endocrine-energy metabolism systems in depression and schizophrenia: Relationships to symptomatology, in Hormones, Behavior and Psychopathology. EJ. Sachar, ed. Raven Press, New York (1976), pp. 237–242.
Huey, L.Y., Janowsky, D.S., Mandell, A.J., Judd, L.L., and Pendery, M. Preliminary studies on the use of thyrotropin releasing hormone in manic states, depression, and the dysphoria of alcohol withdrawal. Psychopharmacol. Bull. 11(1), 24–27 (1975).
Hutton, W. N. Thyrotropin-releasing hormone in depression. Lancet ii, 53 (1974).
Kastin, AJ., Ehrensing, R.H., Schalch, D.S., and Anderson, M.S. Improvement in mental depression with decreased thyrotropin response after administration of thyrotropinreleasing hormone. Lancet ii, 740–742 (1972).
Kirkegaard, C., Bjorum, N., Cohn, D., and Lauridsen, U.B. TRH stimulation test in manic depressive disease. Arch. Gen. Psychiat. 35, 1017–1023 (1978).
Kirkegaard, C., Norlem, N., Lauridsen, U.B., Bjorum, N., and Christiansen, C. Protirelin stimulation test and thyroid function during treatment of depression. Arch. Gen. Psychiat. 32, 1115–1118 (1975).
Kleeman, C.R., and Vorhen, H. Water metabolism and the neurophypophyseal hormones, in Duncan’s Diseases of Metabolism: Endocrinology 7th ed. P.K. Bondy, and L.E. Rosenberg, eds. W.B. Saunders, Co., Philadelphia (1974).
Kline, N.S., Li, C.H., Lehmann, H.E., Lajtha, A., Laski, E., and Cooper, T. β-Endorphininduced changes in schizophrenic and depressed patients. Arch. Gen. Psychiat. 34, 1111–1113 (1977).
Krieger, P.T., Liotta, A., and Brownstein, MJ. Presence of corticotropin in brain of normal and hypophysectomized rats. Proc. Natl. Acad. Sci. USA 74, 648–652 (1977).
Leaf, A., and Coggins, C.H. The neurohypophysis, in Textbook of Endocrinology. R.H. Williams, ed. W.B. Saunders, Philadelphia (1974), pp. 80–94.
Loosen, P.T., and Prange, AJ., Jr. Psycho endocrinology: A brief survey, in Psychiatric Complications of Medical Drugs. R.I. Shader, ed. Raven Press, New York (1979a).
Loosen, P.T., and Prange, AJ., Jr. Thyrotropin response to thyrotropin releasing hormone: Findings in depressed and alcoholic patients, in Alcoholism and Affective Disorders. D.W. Goodwin, and C.K. Erickson, eds. Spectrum Publications, New York (1979b) pp. 145–155.
Loosen, P.T., Prange, AJ., Jr., and Wilson, I.C. Influence of cortisol on TRH induced TSH response in depression. Am. J. Psychiat. 135, 244–246 (1978a).
Loosen, P.T., Prange, AJ., Jr., and Wilson, I.C. The TSH response to TRH in psychiatric patients: Relation to serum cortisol. Prog. Neuropsychopharmacol. 2, 479–486 (1978b).
Loosen, P.T., Prange, AJ., Jr., and Wilson, I.C. Thyrotropin releasing hormone (TRH) in depressed alcoholic men: Behavioral changes and endocrine responses. Arch. Gen. Psychiat. 36, 540–547 (1979).
Loosen, P.T., Wilson, I.C., and Prange, A.J., Jr. Behavioral changes in depression after TRH: Antagonism by pretreatment with thyroid hormones (unpublished data).
Loosen, P.T., Prange, AJ., Jr., Wilson, I.C., and Lara, P.P. Pituitary responses to thyrotropin releasing hormone in depressed patients: A review. Pharmacol. Biochem. Behav. (Suppl. 1), 5, 95–101 (1976).
Loosen, P.T., Prange, AJ., Jr., Wilson, I.C., Lara, P.P., and Pettus, C. Thyroid stimulating hormone response after thyrotropin releasing hormone in depressed, schizophrenic and normal women. Psychoneuroendocrinology 2, 137–148 (1977).
Maeda, K., Kato, Y., Ohgo, S., Chihara, K., Yoshimoto, Y., Yamaguchi, N., Kuromaru, S., and Imura, H. Growth hormone and prolactin release after injection of thyrotropin releasing hormone in patients with depression. J. Clin. Endocrin. Metab. 40, 501–505 (1975).
Mazure, C., and Gershon, E.S. Blindness and reliability in lifetime psychiatric diagnoses. Arch. Gen. Psychiat. 36, 521–525 (1979).
McCann, S.M. and Ojeda, S.R. Synaptic transmitters involved in the release of hypothalamic releasing and inhibitory hormones, in Reviews Neuroscience, Vol. 2. S. Ehrenpreis and I.J. Kopin, eds. Raven Press, New York (1976), pp. 91–110.
Meister, A., and Tate, S.S. Glutathione and related f-glutamyl compounds: Biosynthesis and utilization. Ann. Rev. Biochem. 45, 559–603 (1976).
Moldow, R.L., and Yalow, R.S. Extrahypophyseal distribution of thyrotropin as a function of brain size. Life Sciences 22, 1859–1864 (1978).
Moss, R.L. Relationship between the central regulation of gonadotropin and mating behavior in female rats, in Reproductive Behavior. W. Montagna and W.A. Sadler, eds. Plenum Press, New York (1975), pp. 55–76.
Moss, R.L., and McCann, S.M. Induction of mating behavior in rats by luteinizing hormonereleasing factor. Science 181, 177–179 (1973).
Mueller, P.S., Heninger, G.R., and McDonald, R.K. Studies on glucose utilization and insulin sensitivity in affective disorders, in Recent Advances in the Psychobiology of the Depressive Illness. T.A. Williams, M.M. Kata, and J.A. Shield, Jr., eds. U.S. DHEW Publication 70–9053, U.S. Government Printing Office, Washington, D.C. (1972), pp. 235–248.
Nair, R.M.G., Kastin, A.J., and Schally, A.V. Isolation and Structure of hypothalamic MSH release-inhibiting hormones. Biochem. Biophys. Res. Commun. 43, 1376–1381 (1971).
Nair, R.M.G., Kastin, AJ., and Schally, A.V. Isolation and structure of another hypothalamic peptide possessing MSH-release inhibiting activity. Biochem. Biophys. Res. Commun. 47, 1420–1425 (1972).
Pecknold, J.C., and Ban, T.A. TRH in depressive illness. Pharmacopsychiatry 12, 166–173 (1977).
Pedersen, C.A., and Prange, A.J., Jr. Two hour induction of full maternal behavior in intact virgin rats after intracerebroventricular administration of oxytocin. Tenth Annual Meeting of the International Society for Psychoneuroendocrinology, Park City, Utah, August 8–10, (1979) (Abstract).
Plotnikoff, N.P., Prange, A.J., Jr., Breese, G.R., Anderson, M.S., and Wilson, I.C. The effects of thyrotropin-releasing hormone on DOPA response in normal, hypophysectomized and thyroidectomized animals, in The Thyroid Axis, Drugs, and Behavior. AJ. Prange, Jr., ed. Raven Press, New York (1974), pp. 103–114.
Prange, A.J., Jr. Patterns of pituitary responses to thyrotropin releasing hormone in depressed patients: A review, in Phenomenology and Treatment of Depression. W.E. Fann, I. Karacan, A. Pokorny, and R.L. Williams, eds. Spectrum Publications, New York (1976a), pp. 1–15.
Prange, AJ., Jr., and Lipton, M.A. Hormones and behavior: Some principles and findings, in Psychiatric Complications of Medical Drugs. R.I. Shader, ed. Raven Press, New York (1972a), pp. 213–249.
Prange, AJ., Jr., and Wilson, I.C. Thyrotropin releasing hormone (TRH) for the immediate relief of depression: A preliminary report. Psychopharmacologia 26, 82 (1972b).
Prange, A.J., Jr., Loosen, P.T., and Nemeroff, C.B. Peptides: Application to research in nervous and mental disorders, in New Frontiers of Psychotropic Drug Research. S. Fielding, ed. Futura Publishing Co., Inc., Mt. Kisco, New York (1979), pp. 117–189.
Prange, AJ., Jr., Nemeroff, C. B., and Loosen, P.T. Behavioral effects of hypothalamic peptides, in Centrally Acting Peptides. J. Hughes, ed. MacMillan Press, Ltd., Basingstoke, England (1978a), pp. 99–118.
Prange, AJ., Jr., Breese, G.R., Wilson, I.C., and Lipton, M.A. Brain-behavioral effects of hypothalamic releasing hormones: A generic hypothesis, in Anatomical Neuroendocrinology. W.E. Stumpf and L.D. Grant, eds. S. Karger, Basel (1976b), pp. 357–367.
Prange, A.J., Jr., Lipton, M.A., Nemeroff, C.B., and Wilson, I.C. The role of hormones in depression. Life Sciences 20, 1305–1318 (1977).
Prange, AJ., Jr., Wilson, I.C., Breese, G.R., and Lipton, M.A. Behavioral effects of hypothalamic releasing hormones in animals and man, in Hormones. Homeostasis and the Brain. Progress in Brain Research, Vol. 42. W.H. Gispen, Tj. B. van Wimersma Greidanus, B. Bohus, and D. deWied, eds. Elsevier, Amsterdam (1975), pp. 1–9.
Prange, AJ., Jr., Wilson, I.C., Rabon, A.M., and Lipton, M.A. Enhancement of imipramine antidepressant activity by thyroid hormone. Am. J. Psychiat. 126, 457–469 (1969).
Prange, A.J., Jr., Nemeroff, C.B., Lipton, M.A., Breese, G.R., and Wilson, I.C. Peptides and the central nervous system, in Handbook of Psychopharmacology, Vol. 13. L.L. Iversen, S.D. Iversen, and S.H. Snyder, eds. Plenum Press, New York (1978b), pp. 1–107.
Prange, AJ., Jr., Wilson, I.C., Knox, A., McClane, T.K., and Lipton, M.A. Enhancement of imipramine by thyroid stimulating hormone: Clinical and theoretical implications. Am. J. Psychiat. 127(2), 191–199 (1970).
Prange, AJ., Jr., Wilson, I.C., Lara, P.P., Alltop, L. B., and Breese, G.R. Effects of thyrotropin releasing hormone in depression. Lancet ii, 999–1002 (1972c).
Prange, A.J., Jr., Wilson, I.C., Lynn, C.W., Alltop, L.B., and Stikeleather, R.A. L-tryptophan in mania: Contribution to a permissive hypothesis of affective disorders. Arch. Gen. Psychiat. 30, 56–62 (1974).
Reichlin, S. Neuroendocrinology, in Textbook of Endocrinology. R.H. Williams, ed. W.B. Saunders, Philadelphia (1974), pp. 774–831.
Rinkel, M., Himwich, H.E. Insulin Treatment in Psychiatry. Philosophical Library, New York, (1959).
Sachar, EJ., Finkelstein, J., and Hellman, J. Growth hormone responses in depressive illness. Arch. Gen. Psychiat. 25, 263–269 (1971).
Sachar, E.J., Frantz, A.G., Altman, N., and Sassin, J. Growth hormone and prolactin in unipolar and bipolar depressed patients: Responses to hypoglycemia and L-DOPA. Am. J. Psychiat. 130, 1362–1367 (1973a).
Sachar, E.J., Hellman, L., Roffwarg, H., Halpern, F., Fukushima, D., and Gallagher, T. Disrupted 24 hour patterns of cortisol secretion in psychiatric patients. Arch. Gen. Psychiat. 23, 289–298 (1973b).
Sawin, C.T., and Hershman, J.M. Clinical use of thyrotropin-releasing hormone. Pharmac. Ther. C. 1, 351–366 (1976).
Schally, A. V. Aspects of hypothalamic regulation of the pituitary gland. Science 202, 18–28 (1978).
Schatzberg, A. F. Classification of depressive disorders, in Depression. Biology. Psychodynamics and Treatment. J.O. Cole, A.F. Schatzberg, and S.H. Frazier, eds. Plenum Press, New York (1976), pp. 13–40.
Schild kraut, J.J., Orsulak, P.J., Gudeman, J.E., Schatzberg, A.F., Rohde, W.A., Labrie, R.A., Cahill, J.R., Cole, J.O., and Frazier, S.H. Norepinephrine metabolism in depressive disorders: Implications for classification of depression, in Depression. Biology. Psychodynamics and Treatment. J.O. Cole, A.F. Schatzberg, and S.H. Frazier, eds. Plenum Press, New York (1976), pp. 75–101.
Schmidt, P. Uber organtherapie und insulinbehandlung bei endogenen geistesstorungen. Klin. Woch. 7, 839 (1928).
Shopsin, B., Shenkman, L., Blum, M., and Hollander, C. T3 and TSH response to TRH: Newer aspects of lithium-induced thyroid disturbances in men. Psychopharm. Bull. 9, 29 (1973).
Takahashi, S., Kondo, H., Yoshimura, M., and Ochi, Y. Thyrotropin responses to TRH in depressive illness: relation to clinical sub-types and prolonged duration of depressive episode. Folia Psychiat. Neurol. Jap. 28, 355–365 (1974).
Terenius, L. and Wahlstrom, A. Physiological and clinical relevance of endorphins, in Centrally Acting Peptides. J. Hughes, ed. MacMillan Press, Ltd., London (1978), pp. 161–178.
Terenius, L., Wahlstrom, A., and Agren, A. Naloxone (Narcan) treatment in depression: Clinical observations and effects on CSF endorphin and monoamine metabolites. Psychopharmacology 54, 31–33 (1977).
Vale, W., Rivier, C., and Brown, M. Regulatory peptides of the hypothalamus. A review. Physiology 39, 473–527 (1977).
Vale, W., Brazeau, P., Rivier, C., Rivier, J., Grant, G., Burgus, R., and Guillemin, R. Inhibitory hypophysiotropic activities of hypothalamic somatostatin. Fed. Proc. 32, 211 (1973).
Van den Burg, W., van Praag, H.M., Box, E.R.H., Piers, D.A., van Zanten, A.K., and Doorenbos, H. TRH as a possible quick-acting but short-lasting antidepressant. Psycholog. Med. 5, 404–412 (1975).
Van den Burg, W., van Praag, H.M., Box, E.R.H., Piers, D.A., van Zanten, A.K., and Doorenbos, H. TRH by slow, continuous infusion: an antidepressant. Psycholog. Med. 6, 393–397 (1976).
Verebey, K., Volavka, J., and Clovet, D. Endorphins in psychiatry. Arch. Gen. Psychiat. 35, 877–888 (1978).
Vogel, H.P., Benkert, O., Illig, R., Mueller-Oerlinghausen, B., and Poppenberg, A. Psychoendocrinological and therapeutic effects of TRH in depression. Acta Psychiat. Scand. 56, 223–232 (1977).
Waldstein, S.S. Thyroid-catecholaminic interrelations. Am. Rev. Med. 17, 123–132 (1966).
Weeke, A., and Weeke, J. Disturbed circadian variation of serum thyrotropin in patients with endogenous depression. Acta Psychiat. Scand. 57, 281–289 (1978).
Widerlov, E., and Sjostrom, R. Effects of thyrotropin releasing hormone on endogenous depression. Nordisk Psychiatrisk Tidskrift 29, 503–512, (1975).
Wilson, I.C., Prange, A.J., Jr., and Loosen, P.T. Behavioral effects ofTRH in normal women: antagonism by pretreatment with thyroid hormones (unpublished data).
Wilson, I.C., Prange, A.J., Jr., McClane, T.K., Rabon, A.M., and Lipton, M.A. Thyroid hormone enhancement of imipramine in non-retarded depression. N. Engl. J. Med. 282, 1063–1067 (1970).
Wilson, I.C., Prange, A.J., Jr., Lara, P.P., Alltop, L.B., Stikeleather, R.A., and Lipton, M.A. TRH (lopremone): psychobiological responses of normal women: (I) subjective experience. Arch. Gen. Psychiat. 29, 15–32 (1973).
Winawer, S.J., Sherlock, P., Sonnenberg, M., and Vaneamee, P. Beneficial effect of human growth hormone on stress ulcers. Arch. Intern. Med. 135, 569–572 (1975).
Winokur, A., and Utiger, R.D. Thyrotropin-releasing hormone: Regional distribution in rat brain. Science 185, 265–266 (1974).
Yarbrough, G.G. TRH potentiates excitatory actions of acetylcholine in cerebral cortical neurons. Nature 263, 523–524 (1976).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Spectrum Publications, Inc.
About this chapter
Cite this chapter
Prange, A.J., Loosen, P.T. (1982). Peptides in Affective Disorders. In: Beckman, A.L. (eds) The Neural Basis of Behavior. Springer, Dordrecht. https://doi.org/10.1007/978-94-011-6302-6_11
Download citation
DOI: https://doi.org/10.1007/978-94-011-6302-6_11
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-011-6304-0
Online ISBN: 978-94-011-6302-6
eBook Packages: Springer Book Archive